Table 1.

Effect at PLL on Ascite Fluid Volume, Packed Cell Volume, Body Weight, Mean Survival Time (MST), Percentage Increased Life Span (% ILS), Viable and non-Viable Tumor Cell Count in EAC Bearing Mice

	Poly L-lysine 20 mg/kg b.w	Poly L-lysine 40 mg/kg b.w	Std drug 20 mg/kg b.w	EAC Control(2 x 106 cells/mouse)
Ascite fluid volume (ml.)	6.63 ± 0.18*	4.6 ± 0.04*	5.18 ± 0.29*	11.55 ± 0.05*
Packed Cell volume (ml.)	2.73 ± 0.03*	1.45 ± 0.03*	1.34 ± 0.01*	3.97 ± 0.04*
Body Weight (gm.)	23.64 ± 0.24*	17.08 ± 0.08*	20.4 ± 0.25*	30.6 ± 0.27*
MST (days)	30.86 ± 0.43*	40.55 ± 0.04*	53.05 ± 0.04*	20.14 ± 0.02*
% ILS	56.25 ± 0.04	88.35 ± 0.05	112.35 ± 0.03	0 ± 0
Viable cell (x 106 cells/ml)	3.05 ± 0.03*	1.23 ± 0.02*	3.32 ± 0.03*	10.07 ± 0.04*
Nonviable cell (106 cells/ml)	3.98 ± 0.17*	3.79 ± 0.14*	3.99 ± 0.12*	0.67 ± 0.06*

Each point represent the mean ±SEM. (n=6 mice per group); *p<0.05 statistically significant when compared with EAC control group.